Answers are grounded in this paper and cite their sources.
Reviews recent clinical trials and updated targets for cardiovascular risk factor management in type 2 diabetes, highlighting evolving strategies for primary prevention.
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Fox et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: